BOSTON (SHNS) – The nationwide race to get vaccines in arms hit an surprising snag on Monday when federal regulators beneficial a pause on the administration of the Johnson & Johnson vaccine to assessment six reported situations of a extreme blood clot reported among the many greater than 6.8 million adults who acquired the shot.
U.S. Meals and Drug Administration Appearing Commissioner Dr. Janet Woodcock stated the halt will doubtless final “a matter of days,” noting that the reported incidents seem like “extraordinarily uncommon.” Within the meantime, Massachusetts will observe the federal guideline and cease utilizing the J&J shot, requiring those that already had appointments booked to contact their suppliers.
Gov. Charlie Baker didn’t make any public appearances on Tuesday, however the impacts of the J&J change on the state’s vaccination marketing campaign will doubtless be a central subject at his subsequent press convention.
By Tuesday, Massachusetts had administered 192,920 doses of the single-shot J&J vaccine, representing simply greater than 10 p.c of the 1,833,085 residents who are actually totally vaccinated towards COVID-19. One other 1,640,165 residents have acquired each doses of both the Moderna or Pfizer vaccines, in accordance with state data.
Medical consultants told lawmakers on Tuesday that, whereas they need to see extra sequencing, there’s optimism that the vaccines nonetheless present a worthwhile degree of immunity towards the extra infectious COVID-19 variants spreading in Massachusetts and the nation.
The Division of Public Well being reported 1,401 newly confirmed instances of the virus on Tuesday from 57,829 exams. There have been 714 sufferers in Massachusetts hospitals with COVID-19 counted in Tuesday’s report, a rise of 15 from the day prior.